本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

MBX Biosciences

6.04
-0.3300-5.18%
盤後5.89-0.1500-2.48%19:39 EDT
成交量:47.31萬
成交額:281.36萬
市值:2.02億
市盈率:-1.04
高:6.42
開:6.34
低:5.66
收:6.37
資料載入中...
2025/03/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/17

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/17

重要事件披露

Form 8-K - Current report
2025/01/07

重要事件披露

Form 8-K - Current report
2024/11/08

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/20

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/16

重要事件披露

Form 8-K - Current report
2024/09/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/11

SEC問詢函

Form CORRESP - Correspondence
2024/09/11

SEC問詢函

Form CORRESP - Correspondence
2024/09/09

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/31

SEC問詢函

Form CORRESP - Correspondence